The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

David B. Badesch

Department of Medicine

University of Colorado Denver





Name/email consistency: high



  • Department of Medicine, University of Colorado Denver, Denver, Colorado, USA. 2009
  • Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA. 2007
  • University of Colorado Health Sciences Center, Denver 80262, USA. 1997 - 2007


  1. Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol. Badesch, D.B., McGoon, M.D., Barst, R.J., Tapson, V.F., Rubin, L.J., Wigley, F.M., Kral, K.M., Raphiou, I.H., Crater, G.D. J. Rheumatol. (2009) [Pubmed]
  2. Sildenafil for pulmonary arterial hypertension associated with connective tissue disease. Badesch, D.B., Hill, N.S., Burgess, G., Rubin, L.J., Barst, R.J., Galiè, N., Simonneau, G. J. Rheumatol. (2007) [Pubmed]
  3. Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. Badesch, D.B., Abman, S.H., Simonneau, G., Rubin, L.J., McLaughlin, V.V. Chest (2007) [Pubmed]
  4. Prostanoid therapy for pulmonary arterial hypertension. Badesch, D.B., McLaughlin, V.V., Delcroix, M., Vizza, C.D., Olschewski, H., Sitbon, O., Barst, R.J. J. Am. Coll. Cardiol. (2004) [Pubmed]
  5. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Badesch, D.B., Abman, S.H., Ahearn, G.S., Barst, R.J., McCrory, D.C., Simonneau, G., McLaughlin, V.V. Chest (2004) [Pubmed]
  6. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Badesch, D.B., Tapson, V.F., McGoon, M.D., Brundage, B.H., Rubin, L.J., Wigley, F.M., Rich, S., Barst, R.J., Barrett, P.S., Kral, K.M., Jöbsis, M.M., Loyd, J.E., Murali, S., Frost, A., Girgis, R., Bourge, R.C., Ralph, D.D., Elliott, C.G., Hill, N.S., Langleben, D., Schilz, R.J., McLaughlin, V.V., Robbins, I.M., Groves, B.M., Shapiro, S., Medsger, T.A. Ann. Intern. Med. (2000) [Pubmed]
  7. Clinical trials in pulmonary hypertension. Badesch, D.B. Annu. Rev. Med. (1997) [Pubmed]
WikiGenes - Universities